Antitumor and Antiangiogenic Effects of Somatostatin Receptor-Targeted in Situ Radiation with 111In-DTPA-JIC 2DL
- 15 May 2001
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 97 (2) , 131-137
- https://doi.org/10.1006/jsre.2001.6149
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antiangiogenic tumour therapy: will it work?Trends in Pharmacological Sciences, 1998
- Breast cancer increases initiation of angiogenesis without accelerating neovessel growth rateSurgery, 1997
- Mechanisms of angiogenesisNature, 1997
- Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of actionInvestigational New Drugs, 1997
- Angiogenesis research up to 1996. A commentary on the state of art and suggestions for future studiesEuropean Journal Of Cancer, 1996
- Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic modelsEuropean Journal Of Cancer, 1996
- SST-2 gene expression appears during human angiogenesisRegulatory Peptides, 1996
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor‐host interaction?International Journal of Cancer, 1994
- Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membraneJournal of Surgical Research, 1991